Raphael Jeremiah Landovitz, MD

NPI 1033153028ActiveIndividual· Internal Medicine, Infectious Disease· Los Angeles, CA

Internal Medicine, Infectious Disease (MD) in Los Angeles, California, trained at Harvard Medical School (class of 1996). Their prescriptions cost Medicare Part D more than their services did: $759,277 for 291 claims, against $9,144 paid for services in 2024. Merck Sharp & Dohme LLC was the largest of 2 companies reporting payments in 2025, $26,158 in all, mostly consulting fees.

Overview

NPI	1033153028
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Jun 16, 2006
Last updated in NPPES	Sep 16, 2021
Certified by provider	Sep 16, 2021

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Infectious Disease Primary	207RI0200X	A96826	CA
Internal Medicine	207R00000X	A96826	CA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026	No match	—
New York OMIG · Nov 10, 2026	No match	—
Ohio Medicaid · Nov 10, 2026	No match	—
Pennsylvania Medicheck · Nov 10, 2026	No match	—
Washington HCA · Nov 10, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Infectious Disease (CA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	40
Services billed	117 across 23 procedure codes
Paid by Medicare	$9,144

Part D prescriptions in 2024

Prescriptions (claims)	291 · 407 30-day fills
Patients	21
Total drug cost	$759,277
Generic share	38% of claims

Medicare sources and data years

Education and affiliations

Medical school	Harvard Medical School
Graduation year	1996
Medicare specialty	Infectious Disease
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth